Reprogramming Mediated by Cell Fusion Technology

International Review of Cell and Molecular Biology

Volumn 291, Issue , 2011, Pages 155-190

  Serov, Oleg L ^a   Matveeva, Natalia M ^a   Khabarova, Anna A ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Cell differentiation; Cell fusion; Epigenome; Gene expression; Heterokaryons; Hybrid cells; Reprogramming

Indexed keywords

BOOK; CELL CYCLE; CELL FUSION; CELL HYBRIDIZATION; CELL INTERACTION; CYTOPLASM; EMBRYONIC STEM CELL; EPIGENETICS; GENOME IMPRINTING; HETEROKARYON; HUMAN; HYBRID CELL; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOMATIC CELL;

EID: 80054784426     PISSN: 19376448     EISSN: 19376448     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386035-4.00005-7     Document Type: Chapter

References (141)

1. Allan B. Production and analysis of chimeric mice. Teratocarcinoma and Embryonic Stem Cells: A Practical Approach 1987, 125-139. IRL Press, Oxford, England. E.J. Robertson (Ed.).
2. Ambrosi D.J., Rasmussen T.P. Reprogramming mediated by stem cell fusion. Cell. Mol. Med. 2005, 9:320-330.
3. Ambrosi D.J., Tanasijevic B., Kaur A., Obergfell C., O'Neill R.J., Krueger W., et al. Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells. Stem Cells 2007, 25:1104-1113.
4. Andrews P.W., Goodfellow P.N. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells. Somatic Cell Genet. 1980, 6:271-284.
5. Artzt K., Jacob-Cohen R.J., Dimeo A., Alton A.K., Darling G. Reexpression of a T/t-complex antigen (t12) in thymocyte x embryonal carcinoma cell hybrids. Somatic Cell Genet. 1980, 7:423-434.
6. Atsumi T., Shirayoshi Y., Takeichi M., Ocada T.S. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells. Differentiation 1982, 23:83-86.
7. Axelrod D.E., Gopalakrishnan T.V., Willing M., Anderson W.F. Maintenance of hemoglobin inducibility in somatic cell hybrids of tetraploid (2S) mouse erythroleukemia cells with mouse or human fibroblasts. Somatic Cell Genet. 1978, 4:157-168.
8. Battulin N.R., Pristyazhnyuk I.E., Matveeva N.M., Fishman V.S., Vasilkova A.A., Serov O.L. Allelic expression and DNA methylation profiles of promoters at the parental Oct4 and Nanog genes in Mus musculus ES cell/Mus caroli splenocyte hybrid cells. Cell Tissue Res. 2009, 337:439-448.
9. Battulin N.R., Kruglova A.A., Boyarskih U.A., Menzorov A.G., Filipenko M.L., Serov O.L. Reprogramming somatic cells by fusion with embryonic stem cells does cause not silencing of Dlk1-Dio3 region in mice. World J. Stem Cells 2011, (submitted).
10. Ben-Shushan E., Pikarsky E., Klar A., Berhgman Y. Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region. Mol. Cell. Biol. 1993, 13:891-901.
11. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
12. Blau H.M., Chiu C.-P., Webster C. Cytoplasmic activation of nuclear genes in stable heterocaryons. Cell 1983, 32:1171-1180.
13. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.-K., Silberstein L., Webster S.G., et al. Plasticity of the differentiated state. Science 1985, 230:738-766.
14. Bradly A., Evans M., Kaufman M.H., Robertson E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984, 309:255-256.
15. Brown J.E., Weiss M.C. Activation of production of mouse liver enzymes in rat hepatoma-mouse lymphoid cell hybrids. Cell 1975, 6:481-494.
16. Caiafa P., Zampieri M. DNA methylation and chromatin structure: the puzzling CpG islands. J. Cell. Biochem. 2005, 94:257-265.
17. Campbell K.H.S., McWhir J., Ritchie W.A., Wilmut I. Production of live lambs following nuclear transfer of cultured embryonic disc cells. Theriogenology 1995, 43:181-188.
18. Campbell K.H.S., McWhir J., Ritchie W.A., Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996, 380:64-66.
19. Carlsson S.-A., Savage R.E., Ringertz N.R. Behaviour of differentiated hen nuclei in cytoplasm of rat myoblasts and myotubes. Nature 1970, 228:869-871.
20. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27:1033-1037.
21. Chiu C.-P., Blau H.M. Reprogramming cell differentiation in the absence of DNA synthesis. Cell 1984, 37:879-887.
22. Chiu C.-P., Blau H.M. 5-Azacytidine permits gene activation in a previously noninducible cell type. Cell 1985, 40:417-424.
23. Collas P., Robl J.M. Relationship between nuclear remodeling and development in nuclear transplant rabbit embryos. Biol. Reprod. 1991, 45:455-465.
24. Correani A., Croce C.M. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells. J. Cell. Physiol. 1980, 105:73-79.
25. Cowan C.A., Atienza J., Melton D.A., Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309:1369-1373.
26. Davidson R.L. Regulation of melanin synthesis in mammalian cells: effect of gene dosage on the expression differentiation. Proc. Natl. Acad. Sci. USA 1972, 69:951-955.
27. Davidson R.L., Benda P. Regulation of specific functions of glial cells in somatic hybrids. II. Control of inducibility of glycerol-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 1970, 67:1870-1877.
28. Dewey M.J., Martin D.W., Martin G.R., Mintz B. Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 1977, 74:5564-5568.
29. Di Berardino M.A. Genomic Potential of Differentiated Cells 1997, Columbia University Press, New York.
30. Disseroth A., Velez R., Burk R.D., Minna J., Anderson W.F., Nienhuis A. Extinction of globin gene expression in human fibroblast x mouse erythroleukemia cell hybrids. Somatic Cell Genet. 1976, 2:373-384.
31. Do J.T., Schöler H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004, 22:941-949.
32. Do J.T., Schöler H.R. Comparison of neurosphere cells with cumulus cells after fusion with embryonic stem cells: reprogramming potential. Reprod. Fertil. Dev. 2005, 17:143-149.
33. Do J.T., Han D.W., Schöler H.R. Reprogramming somatic gene activity by fusion with pluripotent cells. Stem Cell Rev. 2006, 2:257-264.
34. Do J.T., Han D.W., Gentile L., Sobek-Klocke I., Stehling M., Lee H.T., et al. Erasure of cellular memory by fusion with pluripotent cells. Stem Cells 2007, 25:1013-1020.
35. Donovan P. Growth factor regulation of mouse primordial germ cell development. Curr. Top. Dev. Biol. 1994, 229:189-225.
36. Duboule D., Croce C.M., Illmensee K. Tissue preference and differentiation of malignant rat x mouse hybrid cells in chimaeric mouse fetuses. EMBO J. 1982, 1:1595-1603.
37. Eakin G.S., Behringer R.R. Tetraploid development in the mouse. Dev. Dyn. 2003, 228:751-766.
38. Eggan K., Akutsu H., Loring J., Jackson-Grusby L., Klemm M., Rideout W.M., et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 2001, 98:6209-6214.
39. Featherstone M.S., McBurney M.W. Formation and fate of heterokaryons involving embryonal carcinoma cells. Somatic Cell Genet. 1981, 7:205-217.
40. Flasza M., Shering A.F., Smith K., Andrews P.W., Talley P., Johnson P.A. Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers. Cloning Stem Cells 2003, 5:339-354.
41. Forejt J., Gregorova S., Dohnal K., Nosek J. Gene expression of differentiated parent in teratocarcinoma cell hybrids. Repression or reprogramming?. Cell Differ. 1984, 15:229-234.
42. Fougère C., Ring E., Ephrussi B. Gene dosage dependence of pigment synthesis in melanoma x fibroblast hybrids. Proc. Natl. Acad. Sci. USA 1972, 69:330-334.
43. Gmür R., Knowles B.B., Solter D. Regulation of phenotype in somatic cell hybrids derived by fusion of teratocarcinoma cell lines with normal or tumor-derived mouse cells. Dev. Biol. 1981, 81:245-254.
44. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
45. Gridina M.M., Serov O.L. Bidirectional reprogramming of mouse embryonic stem cell/fibroblast hybrid cells is initiated at the heterokaryon stage. Cell Tissue Res. 2010, 342:377-389.
46. Guo J., Tacirlioglu R.T., Ngnyen L., Koh K., Jenkin G., Trounson A. Reprogramming factors involved in hybrids and cybrids of human embryonic stem cells with hepatocytes. Cell. Reprogram. 2010, 12:529-541.
47. Gurdon J.B. Adult frogs derived from the nuclei of single somatic cells. Dev. Biol. 1962, 4:256-273.
48. Gurdon J.B. The reversal of cell differentiation. Annu. Rev. Cell Dev. Biol. 2006, 22:1-22.
49. Han D.W., Do J.T., Gentile L., Stehling M., Lee H.T., Schöler H.R. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 2008, 26:445-454.
50. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143:508-525.
51. Harris H. Behavior of differentiated nuclei in heterokaryons of animal cells from different species. Nature 1965, 206:583-588.
52. Harris H., Cook P.R. Synthesis of an enzyme determined by an erythrocyte nucleus in a hybrid cell. J. Cell Sci. 1969, 5:121-133.
53. Harris H., Watkins J.F., Ford C.E., Schoefl G.I. Artificial heterokaryons of animal cells from different species. J. Cell Sci. 1966, 1:1-30.
54. Harris H., Sidebottom E., Grace D.M., Bramwell M.E. The expression of genetic information: a study with hybrid animal cells. J. Cell Sci. 1969, 4:499-525.
55. Hasegawa K., Zhang P., Wei Z., Pomeroy J.E., Lu W., Pera M.F. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion. Stem Cells 2010, 28:1338-1348.
56. Hochedlinger K., Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 2003, 349:275-286.
57. Hochedlinger K., Jaenisch R. Nuclear reprogramming and pluripotency. Nature 2006, 441:1061-1067.
58. Hogan B., Beddington R., Constantini F., Lacy E. Manipulating the Mouse Embryo 1994, Cold Spring Harbor Laboratory Press, Cold Spring Harbor. second ed.
59. Howe W.E., Oshima R.G. Coordinate expression of parietal endodermal functions in hybrids of embryonal carcinoma and endodermal cells. Mol. Cell. Biol. 1982, 2:331-337.
60. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33:245-254.
61. Joyner A.L. Gene Targeting: A Practical Approach 1993, Oxford University Press, Oxford, England.
62. Keefer C.L., Stice S.L., Mathews D.L. Bovine inner cell mass cells as donor nuclei in the production of nuclear transfer embryos and calves. Biol. Reprod. 1994, 50:935-939.
63. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
64. Kimura H., Tada M., Nakatsuji N., Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell. Biol. 2004, 24:5710-5720.
65. Kruglova A.A., Kizilova E.A., Zhelezova A.I., Gridina M.M., Golubitsa A.N., Serov O.L. Embryonic stem cell/fibroblast hybrid cells with near-tetraploid karyotype provide high yield of chimeras. Cell Tissue Res. 2008, 334:371-380.
66. Kruglova A.A., Matveeva N.M., Gridina M.M., Battulin N.R., Karpov A., Kiseleva E.V., et al. Dominance of parental genomes in embryonic stem cell/fibroblast hybrid cells depends on the ploidy of the somatic partner. Cell Tissue Res. 2010, 340:437-450.
67. Lavagnolli T.M.C., Fonseca S.A.S., Serafima R.C., Pereira V.S., Santos E.J., Abdelmassih S., et al. Presumptive germ cells derived from mouse pluripotent somatic cell hybrids. Differentiation 2009, 78:124-130.
68. Liu L., Luo G.Z., Yang W., Zhao X., Zheng Q., Lv Z., et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J. Biol. Chem. 2010, 285:19483-19490.
69. Lyko F., Paro R. Chromosomal elements conferring epigenetic inheritance. Bioessays 1999, 21:824-832.
70. Matveeva N.M., Shilov A.G., Bayborodin S.I., Philimonenko V.V., Rolinskaya I.V., Serov O.L. Hybrids between murine embryonal stem and somatic cells maintain their pluripotency. Dokl. Akad. Nauk. (Russian) 1996, 349:129-132.
71. Matveeva N.M., Shilov A.G., Kaftanovskaya E.M., Maximovsky L.P., Zhelezova A.I., Golubitsa A.N., et al. In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes. Mol. Reprod. Dev. 1998, 50:128-138.
72. Matveeva N.M., Pristyazhnyuk I.E., Temirova S.A., Menzorov A.G., Vasilkova A., Shilov A.G., et al. Unequal segregation of parental chromosomes in embryonic stem cell hybrids. Mol. Reprod. Dev. 2005, 71:305-314.
73. McBurney M.W., Strutt B.J. Fusion of embryonal carcinoma cells to fibroblast cells, cytoplasts, and karyoplasts: Developmental properties of viable fusion products. Exp. Cell Res. 1979, 124:171-180.
74. McBurney M.W., Strutt B.J. Genetic activity of X chromosomes in pluripotent female teratocarcinoma cells and their differentiated progeny. Cell 1980, 21:357-364.
75. McBurney M.V., Featherstone M.S., Kaplan H. Activation of teratocarcinoma-derived hemoglobin genes in teratocarcinoma-Friend cell hybrids. Cell 1978, 15:1323-1330.
76. Medvinsky A., Smith A. Stem cells: fusion brings down barriers. Nature 2003, 422:823-825.
77. Mèvel-Ninio M., Weiss M.C. Immunofluorescence analysis of the time-course of extinction, reexpression, and activation of albumin production in rat hepatoma-mouse fibroblast heterokaryons and hybrids. J. Cell Biol. 1981, 90:339-350.
78. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
79. Miller R.A., Ruddle F.H. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 1976, 9:45-55.
80. Miller R.A., Ruddle F.H. Properties of teratocarcinoma-thymus somatic cell hybrids. Somatic Cell Genet. 1977, 3:247-261.
81. Miller S.C., Pavlath G.K., Blakely B.T., Blau H.M. Muscle cell components dictate hepatocyte gene expression and the distribution of the Golgi apparatus in heterokaryons. Genes Dev. 1988, 2:330-340.
82. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1975, 72:3585-3589.
83. Mise N., Sado T., Tada S., Takagi N. Activation of the inactive X chromosome induced by cell fusion between a murine EC and female somatic cell accompanies reproducible changes in the methylation pattern of the Xist gene. Exp. Cell Res. 1996, 223:193-202.
84. Modinski J.A., Gerhauser D., Lioli B., Winking H., Illmensee K. Nuclear transfer from teratocarcinoma cells into mouse oocytes and eggs. Development 1990, 108:337-348.
85. Nagy A., Rossant J. Production of completely ES-derived fetuses. Gene Targeting: A Practical Approach 1993, 147-179. IRL Press, Oxford, England. A. Joyner (Ed.).
86. Nagy A., Gocza E., Diaz E.M., Prideaux V.R., Ivany M., Markkula M., et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development 1990, 110:815-821.
87. Okuyama K., Takagi N., Sasaki M. Sequential X-chromosome reactivation and inactivation in cell hybrids between murine embryonal carcinoma cells and female rat thymocytes. Exp. Cell Res. 1986, 1164:323-334.
88. Orkin S.H., Harosi F.I., Leder P. Differentiation in erythroleukemic cells and their somatic hybrids. Proc. Natl. Acad. Sci. USA 1975, 72:98-102.
89. Palermo A., Doyonnas R., Bhutani N., Pomerantz J., Alkan O., Blau H.M. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J. 2009, 23:1431-1440.
90. Papaioannou V.E., Gardner R.L., McBurney M.W., Babinet C., Evans M.J. Participation of cultured teratocarcinoma cells in mouse embryogenesis. J. Embryol. Exp. Morphol. 1978, 44:93-104.
91. Papp B., Plath K. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res. 2011, 3:486-501.
92. Pavlath G.K., Blau H.M. Expression of muscle genes in heterokaryons depends on gene dosage. J. Cell Biol. 1986, 102:124-130.
93. Pells S., Di Domenico A.I., Gallagher E.J., McWhir J. Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells 2002, 4:331-338.
94. Pereira C.F., Terranova R., Ryan N.K., Santos J., Morris K.J., Cui W., et al. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet. 2008, 4:e1000170.
95. Peterson J., Weiss M.C. Expression of differentiated functions in rat hepatoma-mouse fibroblast hybrids. Proc. Natl. Acad. Sci. USA 1972, 69:571-575.
96. Pralong D., Mrozik K., Occhiodoro F., Wijesundara N., Sumer H., van Boxtel A.L., et al. A novel method for somatic cell nuclear transfer to mouse embryonic stem cells. Cloning Stem Cells 2005, 7:265-271.
97. Pralong D., Trounson A.O., Verma P.J. Cell fusion for reprogramming pluripotency. Toward elimination of the pluripotent genome. Stem Cell Rev. 2006, 2:331-340.
98. Pristyazhnyuk I.E., Matveeva N.M., Graphodatskii A.S., Serdyukova N.A., Serov O.L. Chromosome composition of interspecies hybrid embryonic stem cells in mice. Cell Tissue Biol. 2010, 4:128-135.
99. Puzakov M.V., Battulin N.R., Temirova S.A., Matveeva N.M., Serdiukova N.A., Graphodatsky A.S., et al. Analysis expression of parental alleles Xist and Gla in interspecific embryonic hybrid cells during induced in vitro inactivation of the X-chromosomes. Russ. J. Dev. Biol. 2007, 38:164-170.
100. Ringertz N.R., Savage R.E. Cell Hybrids 1976, Academic Press, New York, London, San Francisco.
101. Robertson E.J. Embryo-derived stem cell lines. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach 1987, 71-112. IRL Press, Oxford, England. E.J. Robertson (Ed.).
102. Robertson E., Bradley A. Production of permanent cell lines from early embryos and their use in studying developmental problems. Experimental Approaches to Mammalian Embryonic Development 1986, 475-508. Cambridge University Press, Cambridge, England. J. Rossant, R.A. Pedersen (Eds.).
103. Rossant J., McBurney M.W. The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. J. Embryol. Exp. Morphol. 1982, 70:99-112.
104. Rousset J.-P., Dubois P., Lasserre C., Aviles D., Fellous M., Jami J. Phenotype and surface antigens of mouse teratocarcinoma x fibroblast cell hybrids. Somatic Cell Genet. 1979, 5:739-752.
105. Rousset J.-P., Bucchini D., Jami J. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice. Dev. Biol. 1983, 96:331-336.
106. Schaap G.H., Verkerk A., Van Der Kamp A.V.M., Jongking J.F. Selection of proliferating cybrid cells by dual laser flow sorting. Exp. Cell Res. 1982, 140:299-305.
107. Schaap G.H., Devilee P., van Klaveren P., Jongkind F. Gene expression in flow sorted mouse teratocarcinoma x human fibroblast heterokaryons. Differentiation 1984, 26:127-133.
108. Serov O.L., Zhdanova N.S., Pack S.D., Lavrentieva M.V., Shilov A.G., Rivkin M.I., et al. The mink X-chromosome: organization and inactivation. Progress in Clinical and Biological Research 1990, vol. 344:589-619. Wiley-Liss, New York.
109. Serov O., Matveeva N., Kuznetsov S., Kaftanovskaya E., Mittmann J. Embryonic hybrid cells: a powerful tool for studying pluripotency and reprogramming of the differentiated cell chromosomes. An. Acad. Bras. Cienc. 2001, 73:561-568.
110. Silva J., Chambers I., Pollard S., Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 2006, 44:997-1001.
111. Sims M., First N.L. Production of calves by nuclear transfer of nuclei from cultured inner cell mass cells. Proc. Natl. Acad. Sci. USA 1993, 91:6143-6147.
112. Stadtfeld M., Apostolou E., Akutsu H., Fukuda A., Follett P., Natesan S., et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465:175-181.
113. Stewart T.A., Mintz B. Successive generation of mice produced from an established culture line of euploid teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1981, 78:6314-6318.
114. Stice S.L., Robl J.M. Nuclear reprogramming in nuclear transplant rabbit embryos. Biol. Reprod. 1988, 39:657-664.
115. Stice S.L., Strelchenko N.S., Keefer C., Mathews L. Pluripotent bovine embryonic cell lines direct embryonic development following nuclear transfer. Biol. Reprod. 1996, 54:100-110.
116. Strelchenko N., Kukharenko V., Shkumatov A., Verlinsky J., Kuliev A., Verlinsky Y. Reprogramming of human somatic cells by embryonic stem cell cytoplast. Reprod. Biomed. Online 2006, 12:107-111.
117. Sullivan S., Pells S., Hooper M., Gallagher E.D., McWhir J. Nuclear reprogramming of somatic cells by embryonic stem cells is affected by cell cycle stage. Cloning Stem Cells 2006, 8:174-188.
118. Sumer H., Jones K.L., Liu J., Rollo B.N., van Boxtel A.L., Pralong D., et al. Transcriptional changes in somatic cells recovered from ES-somatic heterokaryons. Stem Cells Dev. 2009, 18:1361-1368.
119. Sumer H., Nicholls G., Pinto A.R., Indraharan D., Liu J., Lim M.L., et al. Chromosomal and telomeric reprogramming following ES-somatic cell fusion. Chromosoma 2010, 119:167-176.
120. Surani M.A. Reprogramming of genome function through epigenetic inheritance. Nature 2001, 414:122-128.
121. Surani M.A., Hayashi K., Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 2007, 128:747-762.
122. Tada M., Takahama Y., Abe K., Nakatsuji N., Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 2001, 11:1553-1558.
123. Tada M., Morizane A., Kimura H., Kawasaki H., Ainscough J.F.X., Sasai Y., et al. Pluripotency of reprogrammed somatic genomes in embryonic stem hybrid cells. Dev. Dyn. 2003, 227:504-510.
124. Takagi N. De novo X-chromosome inactivation in somatic hybrid cells between the XO mouse embryonic carcinoma cell and XY rat lymphocyte. Exp. Cell Res. 1983, 145:397-404.
125. Takagi N. Variable X chromosome inactivation patterns in near-tetraploid murine EC x somatic cell hybrid cells differentiated in vitro. Genetica 1993, 88:107-117.
126. Takagi N., Yoshida M.A., Sugawara O., Sasaki M. Reversal of X-inactivation in female mouse somatic cells hybridized with murine teratocarcinoma stem cells in vitro. Cell 1983, 43:1053-1062.
127. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous fusion. Nature 2002, 416:542-545.
128. Terranova R., Pereira C.F., Du Roure C., Merkenschlager M., Fisher A.G. Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming. J. Cell Sci. 2006, 119:2065-2072.
129. Thompson E.B., Gelehrter T.D. Expression of tyrosine aminotransferase activity in somatic cell heterokaryons: evidence for negative control of enzyme expression. Proc. Natl. Acad. Sci. USA 1971, 68:2589-2593.
130. Vasilkova A.A., Kizilova H.A., Puzakov M.V., Shilov A.G., Zhelezova A.I., Golubitsa A.N., et al. Dominant manifestation of pluripotency in embryonic stem cell hybrids with various numbers of somatic chromosomes. Mol. Reprod. Dev. 2007, 74:941-951.
131. Wakayama T., Perry A.C.F., Zuccotti M., Johnson K.R., Yanagimachi R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998, 394:369-394.
132. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422:897-901.
133. Wilmut I., Schniek A.E., McWhir J., Kind A.J., Campbell K.H.S. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
134. Wolpert L., Smith J., Jessel T., Lawrence P., Robertson E., Meyerowitx E. Principles of Development 2006, Oxford University Press, Oxford, England. third ed.
135. Wright W.E. Induction of muscle genes in neural cells. J. Cell Biol. 1984, 98:27-35.
136. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010, 465:704-712.
137. Yang X., Smith S.L., Tian X.C., Lewin H.A., Renard J.-P., Wakayama T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 2007, 39:295-302.
138. Ying Q.-L., Nichols J., Evans E.P., Smith A.G. Changing potency by spontaneous fusion. Nature 2002, 416:545-548.
139. Yu J., Vodyanik M.A., He P., Slukvin I.I., Thomson J.A. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 2006, 24:168-176.
140. Zeuthen J., Stenman S., Fabricius H.-A., Nilsson K. Expression of immunoglobulin synthesis in human myeloma x non-lymphoid cell heterokaryons: evidence for negative control. Cell Differ. 1976, 4:369-383.
141. Zhang F., Pomerantz J.H., Sen G., Palermo G.A., Blau H.M. Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc. Natl. Acad. Sci. USA 2007, 104:4395-4400.